🇰🇷 Oxytocin 5 Usp Units In Dextrose 5% in South Korea

MFDS authorised Oxytocin 5 Usp Units In Dextrose 5% on 17 April 1980

Marketing authorisation

MFDS — authorised 17 April 1980

  • Marketing authorisation holder: NOVARTIS
  • Status: likely_approved

Oxytocin 5 Usp Units In Dextrose 5% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in South Korea

Frequently asked questions

Is Oxytocin 5 Usp Units In Dextrose 5% approved in South Korea?

Yes. MFDS authorised it on 17 April 1980.

Who is the marketing authorisation holder for Oxytocin 5 Usp Units In Dextrose 5% in South Korea?

NOVARTIS holds the South Korean marketing authorisation.